PLASMID DESIGN FOR PRODUCTION OF CHIMERIC ANTIBODIES WITH DEFINED SPECIFICITY IN EUKARYOTES
- Authors: Oksanich A.S.1, Samartseva T.G.1, Faizjuloev E.B.1, Gavrilova N.F.1, Yakovleva I.V.1, Sviridov V.V.1, Zverev V.V.1
-
Affiliations:
- Mechnikov Research Institute of Vaccines and Sera
- Issue: Vol 94, No 6 (2017)
- Pages: 56-63
- Section: Articles
- URL: https://microbiol.crie.ru/jour/article/view/231
- DOI: https://doi.org/10.36233/0372-9311-2017-6-56-63
- ID: 231
Cite item
Full Text
Abstract
About the authors
A. S. Oksanich
Mechnikov Research Institute of Vaccines and Sera
Author for correspondence.
Russian Federation
T. G. Samartseva
Mechnikov Research Institute of Vaccines and SeraRussian Federation
E. B. Faizjuloev
Mechnikov Research Institute of Vaccines and SeraRussian Federation
N. F. Gavrilova
Mechnikov Research Institute of Vaccines and SeraRussian Federation
I. V. Yakovleva
Mechnikov Research Institute of Vaccines and SeraRussian Federation
V. V. Sviridov
Mechnikov Research Institute of Vaccines and SeraRussian Federation
V. V. Zverev
Mechnikov Research Institute of Vaccines and SeraRussian Federation
References
- Деев С.М., Лебеденко Е.Н. Современные технологии создания неприродных антител для клинического применения. Acta Naturae. 2009, 1: 32-50.
- Деев С.М., Лебеденко Е.Н., Петровская Л.Е., Долгих Д.А., Габибов А.Г., Кирпичников М.П. Неприродные антитела и иммуноконъюгаты с заданными свойствами: оптимизация функций через направленное изменение структуры. Успехи химии. 2015, 84 (1): 1-26.
- Ройт А., Бростофф Дж., Мейл Д. Иммунология. М., Мир, 2000.
- Imai S., Mukai Y., Nagano К. et al. Quality enhancement of the non-immune phage scFv library to isolate effective antibodies. Biol. Pharm. Bull. 2006, 29 (7): 1325-1330.
- KreitmanR.J. Immunotoxins for targeted cancer therapy. AAPSJ. 2006, 8 (3): 532-551.
- Pai L.H., Wittes R., Setser A. et al. Treatment of advanced solid tumors with immunotoxin LMB-1: an antibody linked to Pseudomonas exotoxin. Nat. Med. 1996, 2: 350-353.
- Redwan R.M. Animal-derived pharmaceutical proteins. J. Immunoassay Immunochem. 2009, 30 (3): 262-290.
- Teicher B.A., Chari R.V. Antibody conjugate therapeutics: challenges and potential. Clin. Cancer. Res. 2011, 17 (20): 6389-6397.
- Witzig T.E. Radioimmunotherapy for В-cell non-Hodgkin lymphoma. Best Pract. Res. Clin. Haematol. 2006, 19: 655-668.
Supplementary files


